Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-02-25 @ 8:49 PM
Study NCT ID:
NCT02574650
Status:
UNKNOWN
Last Update Posted:
2017-10-27
First Post:
2015-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
Sponsor:
Mitralign, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11
Start Date Type:
None
Primary Completion Date:
2018-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-05
Completion Date Type:
ESTIMATED
First Submit Date:
2015-10-09
First Submit QC Date:
None
Study First Post Date:
2015-10-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-26
Last Update Post Date:
2017-10-27
Last Update Post Date Type:
ACTUAL